Start Your Day Here: Pfizer Update On Kids' Vaccines, Migrant Deportations And More

Published September 20, 2021 at 7:46 AM EDT
A health care worker wearing a mask and a face shield gives a COVID-19 vaccine to a 17-year-old in Los Angeles on Aug. 7.
Patrick T. Fallon/AFP via Getty Images
A 17-year-old receives a first dose of the Pfizer Covid-19 vaccine at a mobile vaccination clinic in Los Angeles on Aug. 7. On Monday, Pfizer said it was seeing promising results from its vaccine trial on kids 5 to 11 years old.

Good morning,

Here are the top stories we're following today:

Vaccines for kids: Pfizer says it is seeing promising results from its trial on coronavirus vaccine effectiveness for 5- to 11-year-olds. It's an important step toward vaccinating younger Americans, but there's still a ways to go before children under 12 can roll up their sleeves.

Border deportations: The Biden administration is working to remove the thousands of migrants, many of them Haitian, from a squalid border camp. Some have been flown back home.

Emmy's takeaways: The awards show fell short, NPR's critics write. While some fan favorites got recognition, the winner list shows an obvious dearth of diversity.

🎧 Also on Up First, our daily podcast, these are the most urgent issues world leaders will tackle at the U.N. General Assembly.

— The Morning Edition live blog team

(Dana Farrington, Rachel Treisman, Nell Clark, Chris Hopkins and Manuela López Restrepo)